Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Herantis Pharma Oyj: Manager's Transactions - Antti Vuolanto


Posted on: 30 Aug 18

Herantis Pharma Oyj: Manager's Transactions - Antti Vuolanto

Herantis Pharma Plc
Company release 30 Aug 2018 at 9:00 am

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Vuolanto, Antti

Position: Other senior manager

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20180828114244_3

____________________________________________

Transaction date: 2018-08-29

Venue not applicable

Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Instrument name: Optio-ohjelma 2016 I (Optio- ja muut erityiset oikeudet P012)

Nature of the transaction: ACCEPTANCE OF A STOCK OPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 10,000 Unit price:  0.00 EUR

Aggregated transactions

(1): Volume: 10,000 Volume weighted average price:  0.00 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com

GlobeNewswire
globenewswire.com

Last updated on: 30/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.